5 completed, 1 active not recruiting, 1 not yet recruiting, 1 recruiting. 3 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Not yet recruiting 1 |
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Endocrine Cancer: new trials by email Literature Review of Endocrine Cancer trials Research Report on Endocrine Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial Psilocybin (high dose), Psilocybin (low dose), PEARL Therapy - Advanced Cancer, Stage IV Solid Tumor Cancer | Phase 2 | Not yet recruiting | University Health Network, Toronto | 46 | 2026-09-14 | 2026-10-15 |
| Study of Acquired Resistance to Alkylator Chemotherapy in Endocrine Neoplasms Core needle biopsy, Phlebotomy - Neuroendocrine (NE) Tumors, Endocrine Cancer | Recruiting | Uppsala University | 94 | 2025-03-01 | 2025-08-14 | |
| Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer Psilocybin - Advanced Cancer, Stage IV Solid Tumor Cancer | Phase 2 | Active not recruiting | University Health Network, Toronto | 15 | 2024-06-06 | 2026-06-22 |
| Symptom Management for YA Cancer Survivors Behavioral Symptom Management for Young Adult Cancer Survivors - Cancer, Young Adult | Not applicable | Completed | Duke University | 65 | 2020-01-22 | 2025-06-29 |
| Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP) Gastrointestinal Cancer, Breast Cancer | Completed | University of Texas Southwestern Medical Center | 32 | 2015-08-01 | 2018-05-11 | |
| QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas AMG 479, Placebo, gemcitabine - Adenocarcinoma of the Pancreas, Advanced Solid Tumors | Phase 3 | Completed | NantCell, Inc. | 800 | 2011-04-07 | 2024-07-16 |
| Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium denosumab - Breast Cancer, Hypercalcemia of Malignancy | Phase 2 | Completed | Amgen | 33 | 2009-11-16 | 2018-10-17 |
| B-Receptor Signaling in Cardiomyopathy Carcinomas, Amyloidosis | Completed | Daniel Bernstein | 99 | 2008-11-01 | 2015-11-17 |
Endocrine Gland Neoplasms (8) · Breast Neoplasms (4) · Neoplasms (4) · Lung Neoplasms (3) · Lymphoma (3) · Melanoma (3) · Colonic Neoplasms (2) · Head and Neck Neoplasms (2) · Hodgkin Disease (2) · Leukemia (2) · Lymphoma, Non-Hodgkin (2) · Multiple Myeloma (2) · Neoplasm Metastasis (2) · Osteosarcoma (2) · Pancreatic Neoplasms (2)
Endocrine System Diseases (8) · Neoplasms by Site (8) · Hemic and Lymphatic Diseases (6) · Neoplasms by Histologic Type (6) · Skin Diseases (6) · Skin and Connective Tissue Diseases (6) · Breast Diseases (4) · Digestive System Diseases (4) · Digestive System Neoplasms (4) · Hematologic Diseases (4) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Lymphatic Diseases (4) · Lymphoproliferative Disorders (4) · Neoplasms (4)
Psilocybin (2) · Biopsy, Large-Core Needle (1) · Denosumab (1) · Gemcitabine (1) · Phlebotomy (1) · ganitumab (1)
University Health Network, Toronto (2) · Amgen (1) · Daniel Bernstein (1) · Duke University (1) · NantCell, Inc. (1) · University of Texas Southwestern Medical Center (1) · Uppsala University (1)
United States (5) · Canada (4) · France (2) · Italy (2) · Poland (2) · Sweden (2) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Czechia (1) · Denmark (1) · Finland (1) · Germany (1)
Caroline S Dorfman (1) · Daniel Bernstein (1) · Joakim Crona, MD PhD (1) · Muhammad Beg, MD (1) · Sarah Hales, MD (1)
PMID 23990665, PMID 36178972, PMID 38851732, PMID 41152967
K08CA245107 (1)